ClinicalTrials.Veeva

Menu

Berberine and Altered Fasting Glucose

A

Azienda di Servizi alla Persona di Pavia

Status

Unknown

Conditions

Glucose Metabolism Disorders

Treatments

Dietary Supplement: Berberine Phytosome

Study type

Interventional

Funder types

Other

Identifiers

NCT05031715
ID 0912/14122018

Details and patient eligibility

About

The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Fasting blood glucose range:100-125 mg/dl

Exclusion criteria

  • Diabetes mellitus

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Dietary supplement
Experimental group
Description:
Berberine Phytosome
Treatment:
Dietary Supplement: Berberine Phytosome

Trial contacts and locations

1

Loading...

Central trial contact

Mariangela Rondanelli

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems